Thus far, the translation of promising results from preclinical stroke research into effective clinical therapy has not met with success (1). Among the numerous possible reasons for this failure, quality problems in some of the basic research or preclinical studies have to be considered. False-positive results, inflated effect sizes, and marginal reproducibility may have overestimated or even affected the potential of novel stroke therapeutics (2). Systematic reviews have found quantitative evidence that low study quality may have introduced a bias into preclinical stroke research (3,4,5). As opposed to many other causes of the 'translational roadblock', study quality is fully under the control of the researcher, and thus a prime target for improvement. Increasingly, funding bodies and review boards overseeing animal experiments are taking a proactive stance, and demand auditable measures of quality control in preclinical research (6). The Stroke Therapy Academic Industry Roundtable (STAIR) recently updated its recommendations for the evaluation of preclinical data on neuroprotective drugs (7) to include good laboratory practice (GLP) issues (8).
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Monitoring, auditing, and standard operating procedures (SOPs) are key elements of quality control in randomized clinical trials (RCTs). It has been proposed that experimental stroke research adapt some of the tools used in clinical stroke research. In particular, stroke laboratories should set up and publish their SOPs (e.g., on their institutional websites), and guarantee that their studies adhere to these standards (9). This is all the more important, as a certain portion of their experiments, evaluations, etc. are not performed by professionals, but rather by students in training who are unaware of these issues.
A standard operating procedure (SOP) is a set of instructions with the force of a directive covering those features of operations that lend themselves to a definite or standardized procedure without loss of effectiveness. The primary purpose of an SOP in experimental stroke research is to guide and standardize working procedures in order to ensure data reliability and integrity. It is crucial that researchers, students and technicians read and follow 3 the SOPs. If this is not the case, SOPs will not only fail to achieve their goal; they will also engender a false sense of security. Failures are often due to technical shortcomings in the SOPs themselves. SOPs should be written by the user, as they must convey a clear instruction.
The user must not only understand the instruction but also be prepared to carry it out.
We in the following introduce for the first time an SOP in experimental stroke research.
Write down what you do, do what is written down!

Introduction
Experimental focal ischemia is most commonly studied after permanent or 
Personnel
Qualifications
In general:
Surgeons need:
• general supervision and instruction,
• the appropriate certification according to FELASA (A/B),
• official registration.
Also required in Germany: 9. The third knot on the LICA is closed to fix the filament in position.
A midline neck incision is
10. The mice receive saline 0.5 ml subcutaneously as volume replenishment.
11. After X min/hours occlusion, the third knot is opened and the filament withdrawn (if reperfusion is intended) 12. All animals receive a second volume replenishment as described above.
13. The remaining filament is cut and the skin is adapted with a surgical suture 14. The body temperature of the mice during surgery is maintained at 36.5°C ± 0.5°C using a heating plate.
For sham operations the filament is inserted to occlude LMCA and withdrawn immediately to allow instant reperfusion (8.) . The subsequent operation is identical to the animals undergoing cerebral ischemia (9.-14.).
A video is available which demonstrates the above described procedure.
Monofilament construction: Animals in cage are marked with bar/dot code at the beginning of the procedure.
Computer program (random number generator) selects animal, and assigns it to concealed treatment arm ('A', 'B', etc.).
Stock solution or pharmaceutical ready for application is prepared by assistant, and randomly assigned code ('A', 'B', etc.).
b. Genetically manipulated animals:
Animals in both cages (e.g. knockout / wildtype) are marked with bar/dot code at the beginning of the procedure. Computer program (random number generator) selects animal and assigns it to concealed experimental arm ('A', 'B', etc.). Blinded intervention whenever possible.
Temperature control:
The body temperature of mice during surgery is maintained at 36.5°C ± 0.5°C using a temperature controlled heating plate. Maintain a body temperature of 36.5 +/-0.5 °C also after reperfusion (for 2 hours) using a heated recovery box.
Outcome assessment
Infarct volume should be evaluated blinded. Functional outcome (more than Bederson Score!) should be assessed as well. Mortality and exclusion of animals have to be reported, including specific causes for exclusion.
Exclusion criteria:
-no stroke, -Problems during induction of MCAo (excessive bleeding, prolonged operation time ≥ 15 min, thread placement).
CAVE:
Especially in genetically manipulated animals, be aware of vascular alterations, which might directly affect stroke outcome
Physiological parameters:
MABP, HR, blood gases, CBF should be measured in selected animals.
Quasi-sterile surgery
Prior to surgery, the surgeon has to scrub his hands. It is advisable to wear clean gown, and non-sterile gloves at all times the animal is being handled. The surgeon has to wear a clean gown, cap and mask during surgery. Surgical gloves ought to be worn. If gloves cannot be used, a surgical hand scrub from tips to elbows must precede every operation.
The necessary components of aseptic techniques in rodents include also sterile instruments, and separate surgical and animal prep areas. The use of glass bead sterilizer for resterilization of instruments during for repetitive procedures is recommended.
• All instruments used must be sterilized prior to each group of surgeries.
• Instruments must be kept on sterile non-porous drapes during use.
• Instruments must be cleaned of blood and debris by brushing or wiping with sterile water or saline and sterile gauze sponges between surgeries.
• If contamination has occurred, instruments must be placed in 70% ethanol or a glass bead sterilizer for the appropriate period of time for the method used to be effective (or the instrument pack replaced by a new sterile instrument pack) between animals.
• If 70% ethanol is used, instruments must be rinsed with sterile water or saline before being used on the next animal.
• Surgical gloves and blades should be changed after contamination.
• Following surgery all instruments must be thoroughly cleaned and rinsed.
Postoperative care:
The animals must be checked daily after surgery for signs of discomfort. The mice could show some weight loss post-surgery. The mice receive mashed food in a petri-dish placed on the floor to encourage eating. The food is replaced daily for seven days.
